ALPS Advisors’s Tectonic Therapeutic TECX Stock Holding History

ALPS Advisors’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$658K	Buy	19,147 +3,861	+25%	+$113K	﹤0.01%	833
2026 Q1	$472K	Sell	15,286 -83	-0.5%	-$2.04K	﹤0.01%	907
2025 Q4	$321K	Buy	+15,369	New	+$286K	﹤0.01%	933
2021 Q2	–	Sell	-6,250	Closed	-$952K	–	922
2021 Q1	$952K	Buy	6,250 +761	+14%	+$124K	0.01%	401
2020 Q4	$918K	Buy	5,489 +1,617	+42%	+$287K	0.01%	396
2020 Q3	$605K	Sell	3,872 -224	-5%	-$45.1K	0.01%	403
2020 Q2	$858K	Buy	+4,096	New	+$844K	0.01%	355

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

ALPS Advisors's TECX Position: Q2 2026 in Review

ALPS Advisors increased its Tectonic Therapeutic (TECX) stake by 25% in Q2 2026, buying an estimated $113K and bringing the position to 19,147 shares worth $658K. The position accounts for ﹤0.01% of the portfolio, ranked #833.

ALPS Advisors first reported a position in TECX in Q2 2020 and has held it in 7 quarters since. The position peaked at $952K in Q1 2021. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

ALPS Advisors held 19,147 shares of Tectonic Therapeutic worth $658K as of Q2 2026.
ALPS Advisors bought 3,861 Tectonic Therapeutic shares in Q2 2026, an estimated $113K.
Tectonic Therapeutic made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #833 holding.
ALPS Advisors first reported a position in Tectonic Therapeutic in Q2 2020 and has held it in 7 quarters since.
ALPS Advisors's Tectonic Therapeutic position peaked at $952K in Q1 2021.
123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.